Qtron Investments LLC Dexcom Inc Transaction History

Qtron Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $169,656 - $216,012	1,538 Added 25.57%	7,553 $856,000
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $454,072 - $746,822	6,015 New	6,015 $746,000
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $192,436 - $224,106	1,711 Added 83.22%	3,767 $484,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $174,718 - $252,209	2,056 New	2,056 $232,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $49,015 - $82,375	-782 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $37,371 - $59,142	782 New	782 $211,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Qtron Investments LLC with notifications on news.